These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35260509)

  • 21. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
    Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
    Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum.
    Look M; Chang D; Sugarbaker PH
    Int J Gynecol Cancer; 2003; 13(6):764-70. PubMed ID: 14675312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures.
    Low RN; Barone RM; Lucero J
    Ann Surg Oncol; 2015 May; 22(5):1708-15. PubMed ID: 25201499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
    Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
    Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice.
    Arjona-Sánchez Á; Durán M; Sánchez-Hidalgo JM; Rufian-Peña S
    Surg Oncol; 2019 Dec; 31():14-15. PubMed ID: 31472328
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index.
    Llueca A; Serra A; Rivadulla I; Gomez L; Escrig J;
    World J Surg Oncol; 2018 Feb; 16(1):37. PubMed ID: 29471831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian cancer.
    Lee JM
    Cancer Treat Res; 2007; 134():375-85. PubMed ID: 17633067
    [No Abstract]   [Full Text] [Related]  

  • 28. Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Bhatt A; Yonemura Y; Mehta S; Benzerdjeb N; Kammar P; Parikh L; Shah MY; Shaikh S; Prabhu A; Mishra S; Sinukumar S; Kepenekian V; Bakrin N; Passot G; Glehen O
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):582-589. PubMed ID: 31757660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary tract surgery in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
    Cascales PA; Gil J; Alarcón CM; Galindo P; Gómez G; Parrilla P
    Cir Esp; 2012 Mar; 90(3):162-8. PubMed ID: 22341613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: a last chance or futile efforts?
    Chua TC; Robertson G; Liauw W; Morris DL
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):478-84. PubMed ID: 21039384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.
    Kitai T
    Surg Today; 2021 Jul; 51(7):1085-1098. PubMed ID: 33185798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of diaphragmatic peritoneal carcinomatosis: surgical anatomy guidelines and results.
    Halkia E; Efstathiou E; Spiliotis J; Romanidis K; Salmas M
    J BUON; 2014; 19(1):29-33. PubMed ID: 24659639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis.
    Lin EK; Hsieh MC; Chen CH; Lu YJ; Wu SY
    Medicine (Baltimore); 2016 Dec; 95(52):e5522. PubMed ID: 28033247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.
    Tabrizian P; Shrager B; Jibara G; Yang MJ; Romanoff A; Hiotis S; Sarpel U; Labow DM
    J Gastrointest Surg; 2014 May; 18(5):1024-31. PubMed ID: 24577736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
    Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical responsibilities in the management of peritoneal carcinomatosis.
    Sugarbaker PH
    J Surg Oncol; 2010 Jun; 101(8):713-24. PubMed ID: 20512948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients.
    So M; Miyamoto T; Murakami R; Abiko K; Hamanishi J; Baba T; Mandai M
    J Gynecol Oncol; 2019 Nov; 30(6):e100. PubMed ID: 31576692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
    Zivanovic O; Sima CS; Iasonos A; Hoskins WJ; Pingle PR; Leitao MM; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2010 Mar; 116(3):351-7. PubMed ID: 20022092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
    Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
    J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.